Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Le Ren Tang Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceuticals. Founded with a heritage dating back to 1921, the company is currently a key subsidiary of the CSPC Pharmaceutical Group. Its extensive product portfolio includes various dosage forms such as pills, tablets, capsules, and granules, primarily targeting cardiovascular, respiratory, and gastrointestinal therapeutic areas. The company operates large-scale, GMP-certified manufacturing facilities that integrate traditional processing techniques with modern industrial technology. Recognized as a "China Time-honored Brand," Le Ren Tang is a leader in the modernization of herbal medicine in the Hebei province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Le Ren Tang Pharmaceutical.